EUVIMEDEUVIMED entdecken
Crossref

Identification of plasmid-encoded extended spectrum β-lactamases produced by a clinical strain of Proteus mirabilis

S Mahrouki, N Ben-Achour, C Chouchani, M Ben-Moussa, O Belhadj

Pathologie Biologie · 2009-05 · 57 (3) · e55-e59

DOI: 10.1016/j.patbio.2008.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathologie Biologie, 2009-05. Verfasst von S Mahrouki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de biochimie et de technobiologie, faculté des sciences de Tunis, campus universitaire1 El-Manar-II, 2092 Tunis, Tunisia. sihem_mahrouki@…. Hauptthemen laut MEDLINE: Plasmids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emergence and dissemination of multiresistant strain of Proteus mirabilis have made infections treatment more difficult that this bacterium is responsible. The aim of this study is to determine the implication of the enzymatic mechanism and to describe the properties of ESBLs (extended spectrum beta-lactamases). A clinical strain of Proteus mirabilis SM514 isolated in the intensive care unit at the Military hospital in Tunisia during the period 2004 was found to be highly resistant to cephalosporins and penicilins. Cells sonicate of the isolate hydrolysed cefotaxime more efficiently than ceftriaxone and ceftazidime and had three beta-lactamases bands of approximate of isoelectric points (pI) of 5.4; 5.6 and superior to 7.6. The specific activities (AS) vary from 5.26 to 7.77U/mg of protein respectively for cefotaxime and the benzylpenicillin. These activities are inhibited by the clavulanic acid and the sulbactam. The values of the IC(50) are respectively 3.7 and 11.7muM. Only the beta-lactamases of pI 5.4 and superior to 7.6 hydrolyze the cefotaxime. Transformant produces the ESBLs of pI 5.4; 7.45 and greater than 7.6. The genes coding for this enzymes are carried by a transferable plasmids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmidsAnti-Bacterial AgentsCephalosporinsCross InfectionDrug Resistance, BacterialDrug Resistance, MultipleHospitals, MilitaryHumansIntensive Care UnitsMicrobial Sensitivity TestsPenicillinsProteus InfectionsProteus mirabilisTunisiabeta-Lactamase Inhibitorsbeta-Lactamases

Substanzen

Anti-Bacterial AgentsCephalosporinsPenicillinsbeta-Lactamase Inhibitorsbeta-Lactamases

Autor:innen und Institutionen

  • Laboratoire de biochimie et de technobiologie, faculté des sciences de Tunis, campus universitaire1 El-Manar-II, 2092 Tunis, Tunisia. sihem_mahrouki@yahoo.fr

Zitieren

APA

Mahrouki, S., Ben-Achour, N., Chouchani, C., Ben-Moussa, M., & Belhadj, O. (2009). Identification of plasmid-encoded extended spectrum β-lactamases produced by a clinical strain of Proteus mirabilis. Pathologie Biologie, 57(3), e55-e59. https://doi.org/10.1016/j.patbio.2008.02.021

Vancouver

Mahrouki S, Ben-Achour N, Chouchani C, Ben-Moussa M, Belhadj O. Identification of plasmid-encoded extended spectrum β-lactamases produced by a clinical strain of Proteus mirabilis. Pathologie Biologie. 2009;57(3):e55-e59. doi:10.1016/j.patbio.2008.02.021

BibTeX
@article{Mahrouki2009,
  author = {Mahrouki, S and Ben-Achour, N and Chouchani, C and Ben-Moussa, M and Belhadj, O},
  title = {Identification of plasmid-encoded extended spectrum β-lactamases produced by a clinical strain of Proteus mirabilis},
  journal = {Pathologie Biologie},
  year = {2009},
  volume = {57},
  number = {3},
  pages = {e55--e59},
  doi = {10.1016/j.patbio.2008.02.021}
}
Kostenlos starten →